Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David P. Southwell currently holds 204,522 shares of ROCKET PHARMACEUTICALS, INC. (RCKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David P. Southwell has been a net seller of RCKT stock. They have purchased $842.2K and sold $11.0M worth of shares.
David P. Southwell's most recent insider trade was on Aug 3, 2026, when they sold 150,000 shares at $0.00 per share.
David P. Southwell serves as Executive at ROCKET PHARMACEUTICALS, INC. (RCKT). They have executed 239 insider transactions totaling $11.8M over their tenure at the company.
David P. Southwell holds the position of Executive at ROCKET PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
David P. Southwell has shown a selling trading pattern, with $842.2K in total purchases and $11.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David P. Southwell was on Apr 12, 2024, when they sold $1.4M worth of RCKT shares. This transaction involved 59,716 shares at $24.22 per share.
David P. Southwell currently owns 204,522 shares of ROCKET PHARMACEUTICALS, INC. (RCKT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David P. Southwell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David P. Southwell has 239 Form 4 filings on record as an insider at ROCKET PHARMACEUTICALS, INC..
Set alerts for David P. Southwell and 40,000+ other insiders.